Praveen Thokala - Publications
Tappenden P, Carroll C, Stevens J, Simpson E, Thokala P, Wong R, Wright J & Auer R (2018)
Ibrutinib for Treating Waldenström’s Macroglobulinaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 1-12.
Fuller GW, Goodacre S, Keating S, Perkins G, Ward M, Rosser A, Gunson I, Miller J, Bradburn M, Thokala P, Harris T, Carson A, Marsh M & Cooper C (2018)
The ACUTE (Ambulance CPAP: Use, Treatment effect and economics) feasibility study: a pilot randomised controlled trial of prehospital CPAP for acute respiratory failure. Pilot and Feasibility Studies, 4(1). View this article in WRRO
Chai JH, Lee CK, Lee HK, Wong N, Teo K, Tan CS, Thokala P, Tang JWT, Tambyah PA, Oh VMS, Loh TP & Yoong J (2018)
Cost-benefit analysis of introducing next-generation sequencing (metagenomic) pathogen testing in the setting of pyrexia of unknown origin. PLoS ONE, 13(4). View this article in WRRO
Wong CKH, Jiao F, Tang EHM, Tong T, Thokala P & Lam CLK (2018)
Direct medical costs of diabetes mellitus in the year of mortality and year before mortality.. Diabetes Obes Metab. View this article in WRRO
Thokala P, Ochalek J, Leech AA & Tong T (2018)
Cost-Effectiveness Thresholds: the Past, the Present and the Future. PharmacoEconomics. View this article in WRRO
Squires H, Pandor A, Thokala P, Stevens JW, Kaltenthaler E, Clowes M, Coleman R & Wyld L (2018)
Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal.. PharmacoEconomics, 36(1), 29-38. View this article in WRRO
Tong T, Thokala P, McMillan B, Ghosh R & Brazier J (2017)
Cost effectiveness of using cognitive screening tests for detecting dementia and mild cognitive impairment in primary care. International Journal of Geriatric Psychiatry, 32(12), 1392-1400. View this article in WRRO
Sadler S, Holmes M, Ren S, Holden S, Jha S & Thokala P (2017)
Cost-effectiveness of antibiotic treatment of uncomplicated urinary tract infection in women: a comparison of four antibiotics. BJGP Open, 1(3). View this article in WRRO
Salleh S, Thokala P, Brennan A, Hughes R & Dixon S (2017)
Discrete Event Simulation-Based Resource Modelling in Health Technology Assessment. PharmacoEconomics, 35(10), 989-1006. View this article in WRRO
Salleh S, Thokala P, Brennan A, Hughes R & Booth A (2017)
Simulation Modelling in Healthcare: An Umbrella Review of Systematic Literature Reviews. PharmacoEconomics, 35(9), 937-949. View this article in WRRO
Crown W, Buyukkaramikli N, Thokala P, Morton A, Sir MY, Marshall DA, Tosh J, Padula WV, Ijzerman MJ, Wong PK & Pasupathy KS (2017)
Constrained Optimization Methods in Health Services Research-An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force.. Value in Health, 20(3), 310-319. View this article in WRRO
Cowie MR, Simon M, Klein L & Thokala P (2017)
The cost-effectiveness of real-time pulmonary artery pressure monitoring in heart failure patients: a European perspective.. Eur J Heart Fail. View this article in WRRO
Bowman K, Delgado J, Henley WE, Masoli JA, Kos K, Brayne C, Thokala P, Lafortune L, Kuchel GA, Ble A, Melzer D & as part of the Ageing Well Programme of the NIHR School for Public Health Research, England (2017)
Obesity in Older People With and Without Conditions Associated With Weight Loss: Follow-up of 955,000 Primary Care Patients. Journals of Gerontology: Series A, 72(2), 203-209. View this article in WRRO
Tappenden P, Harnan S, Ren S, Thokala P, Wong R, Mukuria C, Green C, Pledge S & Tidy J (2017)
Olaparib for Maintenance Treatment of BRCA 1 or 2 Mutated, Relapsed, Platinum-Sensitive Ovarian, Fallopian Tube and Peritoneal Cancer in People Whose Relapsed Disease has Responded to Platinum-Based Chemotherapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics, 35(1), 97-109. View this article in WRRO
Gray AJ, Roobottom C, Smith JE, Goodacre S, Oatey K, O'Brien R, Storey RF, Na L, Lewis SC, Thokala P & Newby DE (2016)
The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA) - a multicentre parallel-group randomised trial to compare early computerised tomography coronary angiography versus standard care in patients presenting with suspected or confirmed acute coronary syndrome: study protocol for a randomised controlled trial.. Trials, 17(1), 579-579. View this article in WRRO
Reddy BP, Thokala P, Iliff A, Warhurst K, Chambers H, Bowker L, Walters SJ, Duenas A & Kelly MP (2016)
Using MCDA to generate and interpret evidence to inform local government investment in public health. EURO Journal on Decision Processes, 4(3), 161-181. View this article in WRRO
Thokala P, Simpson E, Tappenden P, Stevens J, Dickinson K, Ryder S & Harrison P (2016)
Ledipasvir-Sofosbuvir for Treating Chronic Hepatitis C: A NICE Single Technology Appraisal—An Evidence Review Group Perspective. PharmacoEconomics, 34(8), 741-750. View this article in WRRO
Thokala P, Arrowsmith M, Poku E, Martyn-St James M, Anderson J, Foster S, Elliott T & Whitehouse T (2016)
Economic impact of Tegaderm chlorhexidine gluconate (CHG) dressing in critically ill patients. Journal of Infection Prevention, 17(5), 216-223. View this article in WRRO
Thokala P, Devlin N, Marsh K, Baltussen R, Boysen M, Kalo Z, Longrenn T, Mussen F, Peacock S, Watkins J & Ijzerman M (2016)
Multiple criteria decision analysis for health care decision making - An introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force. Value in Health, 19(1), 1-13.
Marsh K, IJzerman M, Thokala P, Baltussen R, Boysen M, Kaló Z, Lönngren T, Mussen F, Peacock S, Watkins J & Devlin N (2016)
Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force. Value in Health, 19(2), 125-137.
Kruger J, Pollard DJ, Basarir H, Thokala P, Cooke D, Clark M, Bond R, Heller S & Brennan A (2015)
Incorporating Psychological Predictors of Treatment Response into Health Economic Simulation Models: A Case Study in Type 1 Diabetes. Medical Decision Making, 35(7), 872-887. View this article in WRRO
Marks L, Hunter DJ, Scalabrini S, Gray J, McCafferty S, Payne N, Peckham S, Salway S & Thokala P (2015)
The return of public health to local government in England: changing the parameters of the public health prioritization debate?. Public Health, 129(9), 1194-1203. View this article in WRRO
Westwood M, van Asselt T, Ramaekers B, Whiting P, Thokala P, Joore M, Armstrong N, Ross J, Severens J & Kleijnen J (2015)
High-sensitivity troponin assays for the early rule-out or diagnosis of acute myocardial infarction in people with acute chest pain: a systematic review and cost-effectiveness analysis. Health Technology Assessment, 19(44), 1-234. View this article in WRRO
Pandor A, Thokala P, Goodacre S, Poku E, Stevens JW, Ren S, Cantrell A, Perkins GD, Ward M & Penn-Ashman J (2015)
Pre-hospital non-invasive ventilation for acute respiratory failure: a systematic review and cost-effectiveness evaluation. Health Technology Assessment, 19(42), 1-102. View this article in WRRO
Simpson EL, Davis S, Thokala P, Breeze PR, Bryden P & Wong R (2015)
Sipuleucel-T for the Treatment of Metastatic Hormone-Relapsed Prostate Cancer: A NICE Single Technology Appraisal; An Evidence Review Group Perspective. PharmacoEconomics, 33(11), 1187-1194. View this article in WRRO
Thokala P, Dixon S & Jahn B (2015)
Resource Modelling: The Missing Piece of the HTA Jigsaw?. PharmacoEconomics, 33(3), 193-203. View this article in WRRO
Dalley C, Basarir H, Wright J, Fernando M, Pearson D, Ward S, Thokala P, Krishnankutty A, Wilson G, Dalton M, Talley P, Barnett D, Hughes D, Porter NR, Reilly JT & Snowden JA (2015) Specialist integrated haematological malignancy diagnostic services: an Activity Based Cost (ABC) analysis of a networked laboratory service model.
Journal of Clinical Pathology. View this article in WRRO
Thokala P, Goodacre S, Ward M, Penn-Ashman J & Perkins GD (2015)
Cost-effectiveness of Out-of-Hospital Continuous Positive Airway Pressure for Acute Respiratory Failure. Annals of Emergency Medicine, 65(5), 556-563.e6. View this article in WRRO
Goodacre S & Thokala P (2015)
The economics of cardiac biomarker testing in suspected myocardial infarction. Clinical Biochemistry, 48(4-5), 213-217.
Reddy BP, Kelly MP, Thokala P, Walters SJ & Duenas A (2014)
Prioritising public health guidance topics in the National Institute for Health and Care Excellence using the Analytic Hierarchy Process. Public Health, 128(10), 896-903. View this article in WRRO
Campbell F, Thokala P, Uttley LC, Sutton A, Sutton AJ, Al-Mohammad A & Thomas SM (2014)
Systematic review and modelling of the cost-effectiveness of cardiac magnetic resonance imaging compared with current existing testing pathways in ischaemic cardiomyopathy. Health Technology Assessment, 18(59), 1-120.
Thokala P, Kruger J, Brennan A, Basarir H, Duenas A, Pandor A, Gillett M, Elliott J & Heller S (2014)
Assessing the cost-effectiveness of type 1 diabetes interventions: the Sheffield type 1 diabetes policy model.. Diabet Med, 31(4), 477-486.
Pandor A, Thokala P, Gomersall T, Baalbaki H, Stevens JW, Wang J, Wong R, Brennan A & Fitzgerald P (2013)
Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation.. Health Technol Assess, 17(32), 1-vi. View this article in WRRO
Collinson PO, Gaze DC, Thokala P & Goodacre S (2013)
Randomised Assessment of Treatment using Panel Assay of Cardiac markers--Contemporary Biomarker Evaluation (RATPAC CBE).. Health Technol Assess, 17(15), v-122.
Kruger J, Brennan A, Thokala P, Basarir H & Heller S (2013) The cost-effectiveness of Dose Adjustment for Normal Eating (DAFNE) structured education in Type 1 diabetes: an update using the Sheffield Type 1 diabetes policy model.
DIABETIC MEDICINE, 30, 133-134.
Thokala P, Baalbaki H, Brennan A, Pandor A, Stevens JW, Gomersall T, Wang J, Bakhai A, Al-Mohammad A, Cleland J, Cowie MR & Wong R (2013)
Telemonitoring after discharge from hospital with heart failure: cost-effectiveness modelling of alternative service designs.. BMJ Open, 3(9), e003250. View this article in WRRO
Goodacre S, Thokala P, Carroll C, Stevens JW, Leaviss J, Al Khalaf M, Collinson P, Morris F, Evans P & Wang J (2013)
Systematic review, meta-analysis and economic modelling of diagnostic strategies for suspected acute coronary syndrome.. Health Technol Assess, 17(1), v-188.
Hyde C, Peters J, Bond M, Rogers G, Hoyle M, Anderson R, Jeffreys M, Davis S, Thokala P & Moxham T (2013)
Evolution of the evidence on the effectiveness and cost-effectiveness of acetylcholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and economic model.. Age Ageing, 42(1), 14-20.
Thokala P & Duenas A (2012)
Multiple criteria decision analysis for health technology assessment.. Value Health, 15(8), 1172-1181.
Thokala P, Goodacre SW, Collinson PO, Stevens JW, Mills NL, Newby DE, Morris F, Kendall J & Stevenson MD (2012)
Cost-effectiveness of presentation versus delayed troponin testing for acute myocardial infarction. Heart, 98(20), 1498-1503.
Bond M, Rogers G, Peters J, Anderson R, Hoyle M, Miners A, Moxham T, Davis S, Thokala P, Wailoo A, Jeffreys M & Hyde C (2012)
The effectiveness and cost-effectiveness of donepezil, galantamine, rivastigmine and memantine for the treatment of Alzheimer's disease (review of Technology Appraisal No. 111): a systematic review and economic model.. Health Technol Assess, 16(21), 1-470.
Thokala P, Scanlan J & Chipperfield A (2012)
Framework for aircraft cost optimization using multidisciplinary analysis. Journal of Aircraft, 49(2), 367-374.
Thokala P, Scanlan J & Chipperfield A (2010)
Life cycle cost modelling as an aircraft design support tool. P I MECH ENG G-J AER, 224(G4), 477-488.
Thokala P & Martins JRRA (2007) Variable-complexity optimization applied to airfoil design. ENG OPTIMIZ, 39(3), 271-286.